Medication-Assisted Treatment (MAT) Centers in West Virginia

Yes. Federal guidance and West Virginia law protect your right to continue FDA-approved MAT while under community supervision. Share your probation-officer contact with the clinic so they can document treatment — probation cannot legally require you to stop mat.

Costs can vary modestly by location — Huntington has more MAT programs competing on price, and several FQHCs offering sliding-scale fees. Rural West Virginia has fewer options, and patients may incur travel costs, but per-visit fees are often comparable.

Yes. West Virginia Medicaid (Mountain Health Trust) covers FDA-approved medications for opioid use disorder, including mat, plus the associated counseling, drug testing, and clinic visits. Specific formulary details (preferred agents, long-acting injectables) vary by plan — check with your West Virginia Medicaid (Mountain Health Trust) managed-care organization.

Yes. Medicare Part B covers methadone through enrolled Opioid Treatment Programs and Part D covers buprenorphine and naltrexone prescriptions. Medicare Advantage plans in West Virginia include the same MAT benefits under the integrated plan structure.

Opioid Treatment Programs dispensing methadone must meet 42 CFR Part 8 standards for admission, dosing, counseling, and take-home criteria. Buprenorphine prescribing follows DEA Schedule III rules for controlled substances, and naltrexone has no scheduling requirement. SAMHSA and West Virginia licensing agencies conduct periodic inspections at all MAT sites.

Typically no — West Virginia family and criminal courts increasingly recognize MAT as standard medical care. Longer continuous treatment is often viewed favorably by courts as evidence of stability. Share treatment documentation with your attorney for court proceedings.

Bring a photo ID, insurance or West Virginia Medicaid (Mountain Health Trust) card (if applicable), and a list of current medications. Proof of address and pharmacy information speed up buprenorphine prescribing. Intake staff will walk you through paperwork at your first visit.

Feeling worse shortly after the first buprenorphine dose can indicate precipitated withdrawal (taken too soon after a full agonist). Call your West Virginia clinic immediately — the team can adjust timing, switch to micro-induction, or provide supportive medication to relieve symptoms.

Methadone can prolong the QTc interval on ECG; West Virginia clinics screen patients with baseline and follow-up ECGs. Buprenorphine and naltrexone do not carry this risk. Patients with cardiac disease can safely use MAT under close cardiology and MAT-team coordination.

Yes. Methadone and buprenorphine are the evidence-based standard of care in pregnancy, endorsed by ACOG and SAMHSA. Staying on MAT protects both mother and fetus; unmedicated withdrawal is riskier than continued MAT. West Virginia providers coordinate care with obstetrics.

Yes. Family counseling is a standard component of many West Virginia MAT programs; sessions with a partner, parent, or adult child can be scheduled with the patient’s consent. Al-Anon and Nar-Anon groups provide parallel support for family members.

Buprenorphine and naltrexone prescriptions appear on pharmacy records like other prescriptions and are visible to dispensing pharmacies and authorized users of the PDMP. Methadone dispensed at an OTP is not reported to retail pharmacy systems.